Search:   [Advanced]

Search Results

Search for "Delavirdine" returned 43 results

previous123next

Showing 1-20 out of 43

DrugBank ID	Name	Formula	Weight
DB00705	Delavirdine	C22H28N6O3S	456.5610
	... Carbamazepine The anticonvulsant decreases the effect of delavirdine Cisapride Increased risk of cardiotoxicity adn arrhythmias Dihydroergotamine The antiretroviral agent may increase the ...
DB01378	Magnesium	Mg	24.3050
	... complexes Clodronate Formation of non-absorbable complexes Delavirdine The antiacid decreases the absorption of delavirdine Demeclocycline Formation of non-absorbable complexes ...
DB01373	Calcium	Ca	40.0780
	... complexes Delavirdine The antiacid decreases the effect of delavirdine Demeclocycline Formation of non-absorbable complexes Doxycycline Formation of non-absorbable complexes Enoxacin Formation ...
DB00615	Rifabutin	C46H62N4O11	847.0047
	... levels of dapsone Delavirdine Rifabutin decreases the effect of delavirdine Desipramine The rifamycin decreases the effect of tricyclics Dicumarol The rifamycin decreases the anticoagulant ...
DB00701	Amprenavir	C25H35N3O6S	505.6270
	... The protease inhibitor increases the effect of cyclosporine Delavirdine Decreased levels of delavirdine with increased levels of amprenavir Diazepam Increases the effect and toxicity of ...
DB01319	Fosamprenavir	C25H36N3O9PS	585.6070
	... the effect of cyclosporine Delavirdine Decreased levels of delavirdine with increased levels of amprenavir Diazepam Amprenavir increases the effect and toxicity of benzodiazepine Dicumarol The ...
DB00247	Methysergide	C21H27N3O2	353.4580
	... Risk of ergotism and severe ischemia with this association Delavirdine The antiretroviral agent may increase the ergot derivative toxicity Efavirenz The antiretroviral agent may increase the ...
DB00404	Alprazolam	C17H13ClN4	308.7650
	... of the benzodiazepine Clozapine Increased risk of toxicity Delavirdine The antiviral agent increases the effect and toxicity of benzodiazepine Digoxin The benzodiazepine increases the effect ...
DB00637	Astemizole	C28H31FN4O	458.5703
	... Clarithromycin Increased risk of cardiotoxicity and arrhythmias Delavirdine Increased risk of cardiotoxicity and arrhythmias Efavirenz Increased risk of cardiotoxicity and arrhythmias ...
DB00440	Trimethoprim	C14H18N4O3	290.3177
	... changes in therapeutic and adverse effects of Trimethoprim if Delavirdine is initiated, discontinued or dose changed. Dofetilide Trimethoprim may significantly reduced the clearance of Dofetilide.
DB00444	Teniposide	C32H32O13S	656.6540
	... for changes in the therapeutic/adverse effects of Teniposide if Delavirdine is initiated, discontinued or dose changed. Fosamprenavir The strong CYP3A4 inhibitor, Fosamprenavir, may decrease ...
DB00906	Tiagabine	C20H25NO2S2	375.5480
	... for changes in the therapeutic/adverse effects of Tiagabine if Delavirdine is initiated, discontinued or dose changed. Fosamprenavir The strong CYP3A4 inhibitor, Fosamprenavir, may decrease ...
DB00224	Indinavir	C36H47N5O4	613.7895
	... inhibitor increases the effect of cyclosporine Delavirdine Delavirdine increases the effect of indinavir Diazepam The protease inhibitor increases the effect of the benzodiazepine Dicumarol ...
DB00564	Carbamazepine	C15H12N2O	236.2686
	... Danazol Danazol increases the effect of carbamazepine Delavirdine The anticonvulsant decreases the effect of delavirdine Desipramine The tricyclic increases the effect of carbamazepine ...
DB01174	Phenobarbital	C12H12N2O3	232.2353
	... Delavirdine The anticonvulsant decreases the effect of delavirdine Dexamethasone The barbiturate decreases the effect of the corticosteroid Dicumarol The barbiturate decreases the ...
DB00214	Torasemide	C16H20N4O3S	348.4200
	Delavirdine Delavirdine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate ...
DB00897	Triazolam	C17H12Cl2N4	343.2100
	... of the benzodiazepine Clozapine Increased risk of toxicity Delavirdine The antiviral agent increases the effect and toxicity of benzodiazepine Diltiazem The calcium channel blocker increases ...
DB06287	Temsirolimus	C56H87NO16	1030.2871
	Concomitant therapy should be avoided. Delavirdine Delavirdine may inhibit the metabolism and clearance of Temsirolimus. Concomitant therapy should be avoided. Dexamethasone Dexamethasone may ...
DB00227	Lovastatin	C24H36O5	404.5396
	... Risk of severe myopathy/rhabdomyolysis with this combination Delavirdine The NNRT inhibitor increases the effect and toxicity of the statin Dicumarol The statin increases the anticoagulant ...
DB00683	Midazolam	C18H13ClFN3	325.7670
	... effect of benzodiazepine Clozapine Increased risk of toxicity Delavirdine The antiviral agent increases the effect and toxicity of benzodiazepine Diltiazem The calcium channel blocker ...

Showing 1-20 out of 43

previous123next

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.